Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cempra Inc (NASDAQ:CEMP)

17.41
Delayed Data
As of Jun 24
 -1.15 / -6.20%
Today’s Change
14.03
Today|||52-Week Range
46.99
-44.07%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$894.6M

Company Description

Cempra, Inc. engages as a clinical-stage pharmaceutical company, which focuses on the development of antibacterials to meet critical medical needs. Its antibiotic candidates includs Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is headquartered in Chapel Hill, NC.

Contact Information

Cempra, Inc.
Building Two Quadrangle
Chapel Hill North Carolina 27517
P:(919) 313-6601
Investor Relations:

Employees

Shareholders

Mutual fund holders45.57%
Other institutional36.10%
Individual stakeholders21.94%

Top Executives

Prabhavathi B. FernandesPresident, Chief Executive Officer & Director
Mark W. HahnChief Financial Officer & Executive Vice President
David OldachChief Medical Officer
David S. MooreChief Commercial Officer & Executive VP
David PereiraSenior Vice President